Disclosure

"Disclosure" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
Revealing of information, by oral or written communication.


expand / collapse Publications
This graph shows the total number of publications written about "Disclosure" by people in this website by year, and whether "Disclosure" was a major or minor topic of these publications.
Below are the most recent publications written about "Disclosure" by people in Profiles.
  1. Parkinson's disease variant detection and disclosure: PD GENEration, a North American study. Brain. 2024 Aug 01; 147(8):2668-2679.
    View in: PubMed
  2. Dementia Specialty Care Clinicians' Perspectives on Their Role in the Dementia Diagnostic Process and Diagnostic Disclosure. J Geriatr Psychiatry Neurol. 2025 Jan; 38(1):3-12.
    View in: PubMed
  3. Evaluation of mailed results versus telephone disclosure of normal cancer genetic test results in a low-risk underserved population. Transl Behav Med. 2024 Jun 27; 14(7):377-385.
    View in: PubMed
  4. Variability of Guidelines and Disclosures for AI-Generated Content in Top Surgical Journals. Surg Innov. 2024 Aug; 31(4):389-391.
    View in: PubMed
  5. Reporting on Health and War in Medical Journals. JAMA. 2024 04 23; 331(16):1368.
    View in: PubMed
  6. The impact of non-disclosure of HIV status and antiretroviral therapy on HIV recency testing and incidence algorithms. Vox Sang. 2024 Jun; 119(6):581-589.
    View in: PubMed
  7. A controlled trial of adaptive disclosure-enhanced to improve functioning and treat posttraumatic stress disorder. J Consult Clin Psychol. 2024 Mar; 92(3):150-164.
    View in: PubMed
  8. Financial conflicts of interest among presenters, panellists and moderators at haematology and oncology FDA workshops. Eur J Clin Invest. 2024 Jun; 54(6):e14184.
    View in: PubMed
  9. Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead. J Med Chem. 2024 02 22; 67(4):2369-2378.
    View in: PubMed
  10. Post-disclosure distress among racial and ethnic groups in a preclinical AD trial. Alzheimers Dement. 2024 04; 20(4):2508-2515.
    View in: PubMed